SCHEMBL20857780

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL21718194	0.89	PGR (0.33)	MAPTMEN1KMT2AKDM4EDUSP3
	SCHEMBL21126730	0.88	PGR (0.33)	—
	SCHEMBL21718212	0.87	PGR (0.32)	ALKBH5FTO
	SCHEMBL24734838	0.85	—	—
	SCHEMBL21717500	0.83	KDM4E (0.33)	MAPTMEN1KMT2AKDM4EMAPK1
	SCHEMBL21717881	0.83	PGR (0.33)	MAPTMEN1KMT2AKDM4EALKBH5
	SCHEMBL20857787	0.82	KDM4E (0.35)	MAPTMEN1KMT2AKDM4EALDH1A1
	SCHEMBL21126725	0.82	PGR (0.33)	ALKBH5FTO
	SCHEMBL24026756	0.82	—	—
	SCHEMBL24026763	0.82	—	—

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 64 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.